Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (RA, SLE, Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) - Global Forecast to 2022

自己免疫疾患診断の世界市場予測(~2022年):消耗品、アッセイキット、装置、サービス

◆タイトル:Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (RA, SLE, Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) - Global Forecast to 2022
◆商品コード:MAM-MD-5936
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年1月29日
◆ページ数:123
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、自己免疫疾患診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、検査種類別分析、疾患別分析、需要先別分析、自己免疫疾患診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global autoimmune disease diagnosis market is expected to reach USD 4.73 Billion by 2022 from USD 3.09 Billion in 2017, at a CAGR of 8.9%. The growing incidence of autoimmune diseases along population, technological advancements in analyzing devices, increasing access to medical insurance in the US, and increasing healthcare expenditure are key factors driving the growth of this market.
The global market is segmented by product and service, test type, disease, end user, and regions. By product and service, the global market is segmented into consumables and assay kits, instruments, and service. The consumables and assay kits segment is estimated to account for the largest market share of the global market in 2017. Factors driving the growth of this segment include the increasing adoption of consumables and assay kits and bulk buying of these products.

By test type, the market is classified into routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests, and other tests. The routine laboratory tests segment is estimated to account for the largest share of the global autoimmune disease diagnosis market during the next five years. Increasing adoption of routine tests in the diagnosis of chronic disease is very high which is driving the growth of this market.

By disease, the market is classified systemic lupus erythematosus, rheumatoid arthritis, Sjögren’s syndrome, thyroiditis, scleroderma, and other diseases. In 2017, the rheumatoid arthritis segment is estimated to account for the largest share of the global market. The growth of this segment is mainly driven by the increasing incidences of the disease.

On the basis of end user, the autoimmune disease market is segmented into clinical laboratories, hospitals, and other end users. In 2017, the clinical laboratories segment is estimated to account for the largest share of the global market. Growth in the number of clinical laboratories coupled with better accessibility and availability of instruments are major factors driving the growth of this end-user segment.

Autoimmune Disease Diagnosis Market

The global autoimmune disease diagnosis market is dominated by North America, followed by Asia. North America will continue to dominate the global market during the forecast period. However, Asia is expected to witness the highest CAGR during the forecast period with growth centered at China, India, and Japan. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the market in this region.
The factors such as high degree of consolidation, high cost of instruments, and complex regulatory framework for the approval of new products may restrain market growth.

Major industry players launched innovative products to maintain and improve their position in the autoimmune disease diagnosis market. Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), HYCOR Biomedical (US), Siemens AG (Germany), Bio-Rad Laboratories, Inc. (US), and Abbott Laboratories (US) have been identified as the key players in this market. These companies have a broad product portfolio with comprehensive features and have also launched innovative products. These leaders have products for all end users in this market, a strong geographical presence, and focus on continuous product innovations.

【レポートの目次】

1 Introduction (Page No. – 13)
1.1 Objectives of the Study
1.2 Definition
1.3 Study Scope
1.4 Years Considered for the Study
1.5 Currency
1.6 Limitations
1.7 Stakeholders

2 Research Methodology (Page No. – 16)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Data Triangulation

3 Executive Summary (Page No. – 23)

4 Premium Insights (Page No. – 27)
4.1 Attractive Market Opportunities in Autoimmune Disease Diagnosis Market
4.2 Asia: Market, By Test Type
4.3 Geographical Snapshot of the Global Market
4.4 Global Market, By End User

5 Market Overview (Page No. – 31)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Incidence and Large Economic Burden of Autoimmune Diseases
5.2.1.2 Increasing Access to Medical Insurance in the US
5.2.2 Restraints
5.2.2.1 High Capital Requirements
5.2.3 Opportunities
5.2.3.1 Growth Opportunities in Emerging Countries
5.2.3.2 Increasing Number of Awareness Programs for Autoimmune Diseases
5.2.4 Trends
5.2.4.1 Growth in the Number of Reagent Rental Agreements

6 Autoimmune Disease Diagnosis Market, By Product & Service (Page No. – 35)
6.1 Introduction
6.2 Consumables and Assay Kits
6.3 Instruments
6.4 Services

7 Autoimmune Disease Diagnosis Market, By Test Type (Page No. – 40)
7.1 Introduction
7.2 Routine Laboratory Tests
7.3 Inflammatory Markers
7.4 Autoantibodies and Immunologic Tests
7.5 Other Tests

8 Autoimmune Disease Diagnosis Market, By Disease (Page No. – 45)
8.1 Introduction
8.2 Rheumatoid Arthritis
8.3 Systemic Lupus Erythematosus
8.4 Sjögren’s Syndrome
8.5 Thyroiditis
8.6 Scleroderma
8.7 Other Diseases

9 Autoimmune Disease Diagnosis Market, By End User (Page No. – 52)
9.1 Introduction
9.2 Clinical Laboratories
9.3 Hospitals
9.4 Other End Users

10 Autoimmune Disease Diagnosis Market, By Region (Page No. – 57)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.4 Asia
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia (RoA)
10.5 Rest of the World

11 Competitive Landscape (Page No. – 85)
11.1 Overview
11.2 Market Share Analysis, 2016
11.3 Competitive Scenario
11.3.1 Product Launches
11.3.2 Partnerships
11.3.3 Acquisitions
11.3.4 Collaborations

12 Company Profiles (Page No. – 89)
(Business Overview, Products Offered, MnM View.)*
12.1 Siemens
12.2 Abbott
12.3 Thermo Fisher Scientific
12.4 Danaher
12.5 Bio-Rad Laboratories
12.6 GRIFOLS
12.7 Trinity Biotech
12.8 Inova Diagnostics
12.9 HYCOR Biomedical
12.10 Euroimmun
12.11 Protagen

*Business Overview, Products Offered, MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 112)
13.1 Insights From Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details

List of Tables (64 Tables)

Table 1 Autoimmune Disease Diagnosis Market, By Products & Services,, 2015–2022 (USD Million)
Table 2 Autoimmune Disease Diagnosis Consumables and Assay Kits Market,, By Region, 2015–2022 (USD Million)
Table 3 Autoimmune Disease Diagnosis Instruments Market, By Region,, 2015–2022 (USD Million)
Table 4 Autoimmune Disease Diagnosis Services Market, By Region,, 2015–2022 (USD Million)
Table 5 Global Market, By Test Type,, 2015–2022 (USD Million)
Table 6 Global Market for Routine Laboratory Tests, By Region, 2015–2022 (USD Million)
Table 7 Global Market for Inflammatory Markers,, By Region, 2015–2022 (USD Million)
Table 8 Global Market for Autoantibodies and Immunologic Tests, By Region, 2015–2022 (USD Million)
Table 9 Global Market for Other Tests, By Region, 2015–2022 (USD Million)
Table 10 Autoimmune Disease Diagnosis Market, By Disease,, 2015–2022 (USD Million)
Table 11 Global Market for Rheumatoid Arthritis,, By Region, 2015–2022 (USD Million)
Table 12 Global Market for Sle, By Region,, 2015–2022 (USD Million)
Table 13 Global Market for Sjögren’s Syndrome,, By Region, 2015–2022 (USD Million)
Table 14 Global Market for Thyroiditis, By Region,, 2015–2022 (USD Million)
Table 15 Global Market for Scleroderma, By Region, 2015–2022 (USD Million)
Table 16 Global Market for Other Diseases, By Region, 2015–2022 (USD Million)
Table 17 Global Market, By End User,, 2015–2022 (USD Million)
Table 18 Global Market for Clinical Laboratories,, By Region, 2015–2022 (USD Million)
Table 19 Global Market for Hospitals, By Region,, 2015–2022 (USD Million)
Table 20 Global Market for Other End Users, By Region, 2015–2022 (USD Million)
Table 21 Global Market, By Region,, 2015–2022 (USD Million)
Table 22 North America: Autoimmune Disease Diagnosis Market, By Country, 2015–2022 (USD Million)
Table 23 North America: Market, By Product, & Service, 2015–2022 (USD Million)
Table 24 North America: Market, By Test Type, 2015–2022 (USD Million)
Table 25 North America: Market, By Disease, 2015–2022 (USD Million)
Table 26 North America: Market, By End User, 2015–2022 (USD Million)
Table 27 US: Autoimmune Disease Prevalence, 2016
Table 28 US: Market, By Product & Service,, 2015–2022 (USD Million)
Table 29 US: Market, By Test Type,, 2015–2022 (USD Million)
Table 30 US: Market, By Disease,, 2015–2022 (USD Million)
Table 31 US: Market, By End User,, 2015–2022 (USD Million)
Table 32 Canada: Autoimmune Disease Diagnosis Market, By Product & Service, 2015–2022 (USD Million)
Table 33 Canada: Market, By Test Type,, 2015–2022 (USD Million)
Table 34 Canada: Market, By Disease,, 2015–2022 (USD Million)
Table 35 Canada: Market, By End User,, 2015–2022 (USD Million)
Table 36 Europe: Market, By Product & Service, 2015–2022 (USD Million)
Table 37 Europe: Market, By Test Type,, 2015–2022 (USD Million)
Table 38 Europe: Market, By Disease,, 2015–2022 (USD Million)
Table 39 Europe: Market, By End User,, 2015–2022 (USD Million)
Table 40 Asia: Autoimmune Disease Diagnosis Market, By Country,, 015–2022 (USD Million)
Table 41 Asia: Market, By Product & Service, 2015–2022 (USD Million)
Table 42 Asia: Market, By Test Type,, 2015–2022 (USD Million)
Table 43 Asia: Market, By Disease,, 2015–2022 (USD Million)
Table 44 Asia: Market, By End User,, 2015–2022 (USD Million)
Table 45 China: Market, By Product & Service, 2015–2022 (USD Million)
Table 46 China: Market, By Test Type,, 2015–2022 (USD Million)
Table 47 China: Market, By Disease,, 2015–2022 (USD Million)
Table 48 China: Market, By End User,, 2015–2022 (USD Million)
Table 49 Japan: Autoimmune Disease Diagnosis Market, By Product & Service, 2015–2022 (USD Million)
Table 50 Japan: Market, By Test Type,, 2015–2022 (USD Million)
Table 51 Japan: Market, By Disease,, 2015–2022 (USD Million)
Table 52 Japan: Market, By End User,, 2015–2022 (USD Million)
Table 53 India: Market, By Product & Service, 2015–2022 (USD Million)
Table 54 India: Market, By Test Type,, 2015–2022 (USD Million)
Table 55 India: Market, By Disease,, 2015–2022 (USD Million)
Table 56 India: Market, By End User,, 2015–2022 (USD Million)
Table 57 RoA: Autoimmune Disease Diagnosis Market, By Product & Service, 2015–2022 (USD Million)
Table 58 RoA: Market, By Test Type,, 2015–2022 (USD Million)
Table 59 RoA: Market, By Disease,, 2015–2022 (USD Million)
Table 60 RoA: Market, By End User,, 2015–2022 (USD Million)
Table 61 RoW: Market, By Product & Service, 2015–2022 (USD Million)
Table 62 RoW: Market, By Test Type,, 2015–2022 (USD Million)
Table 63 RoW: Market, By Disease,, 2015–2022 (USD Million)
Table 64 RoW: Market, By End User,, 2015–2022 (USD Million)

List of Figures (36 Figures)

Figure 1 Market Segmentation
Figure 2 Research Design
Figure 3 Autoimmune Disease Diagnosis Market: Bottom-Up Approach
Figure 4 Global Market: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Assumptions
Figure 7 Global Market, By Products & Services, , 2017 vs 2022 (USD Million)
Figure 8 Global Market, By Test Type, , 2017 vs 2022 (USD Million)
Figure 9 Autoimmune Disease Diagnosis Market, By Disease, , 2017 vs 2022 (USD Million)
Figure 10 Global Market, By End User, , 2017 vs 2022 (USD Million)
Figure 11 Global Market, By Region, , 2017 vs 2022 (USD Million)
Figure 12 High Incidence & Large Economic Burden of Autoimmune Diseases—Major Factor Expected to Drive Market Growth
Figure 13 Routine Laboratory Tests Segment to Dominate the Asian Autoimmune Disease Diagnosis Market in 2017
Figure 14 North America to Account the Highest Market Share in 2017
Figure 15 Clinical Laboratories to Dominate the Global Market in 2017
Figure 16 Autoimmune Disease Diagnosis Market: Drivers, Restraints, Opportunities, & Trends
Figure 17 Consumables and Assay Kits to Form the Largest Product Segment, in 2017
Figure 18 Routine Laboratory Tests to Form the Largest Test Type Segment, in 2017
Figure 19 Rheumatoid Arthritis to Form the Largest Disease Segment in 2017
Figure 20 Clinical Laboratories to Form the Largest End-User Segment in 2017
Figure 21 Global Market, By Region, , 2017 vs 2022 (USD Million)
Figure 22 North America: Market Snapshot
Figure 23 Consumables & Assay Kits to Dominate the North American Market, By Product & Service, in 2017
Figure 24 Routine Laboratory Tests to Dominate the European Autoimmune Disease Diagnosis Market in 2017
Figure 25 Asia: Market Snapshot
Figure 26 Rheumatoid Arthritis to Dominate the Asian Market in 2017
Figure 27 Clinical Laboratories Segment to Register the Highest Growth Rate in the RoW Market Between 2017 & 2022
Figure 28 Product Launches, the Most Adopted Growth Strategy From , 2014 to 2017
Figure 29 Shares of Top Companies in the Global Market 2016
Figure 30 Siemens: Company Snapshot
Figure 31 Abbott: Company Snapshot
Figure 32 Thermo Fisher Scientific: Company Snapshot
Figure 33 Danaher: Company Snapshot
Figure 34 Bio-Rad Laboratories: Company Snapshot
Figure 35 GRIFOLS: Company Snapshot
Figure 36 Trinity Biotech: Company Snapshot



【レポートのキーワード】

自己免疫疾患診断、消耗品、自己免疫疾患診断アッセイキット、自己免疫疾患診断装置、自己免疫疾患診断サービス、炎症マーカー、自己抗体

★調査レポート[自己免疫疾患診断の世界市場予測(~2022年):消耗品、アッセイキット、装置、サービス] ( Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (RA, SLE, Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) - Global Forecast to 2022 / MAM-MD-5936) 販売に関する免責事項
[自己免疫疾患診断の世界市場予測(~2022年):消耗品、アッセイキット、装置、サービス] ( Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (RA, SLE, Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) - Global Forecast to 2022 / MAM-MD-5936) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆